...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Great Presetation today
Reply New Message
Prev Message Back To Forum Threaded View Next Message

And Zenith is on the schedule for BIO Europe coming up Nov 6-8 in Berlin, so maybe we'll see an updated data set on the combo trial then. I think Zenith presents Nov 7th as of the schedule I saw 10/20.

2 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply